FI961339A - Triaryletenderivat för användning i terapi - Google Patents
Triaryletenderivat för användning i terapi Download PDFInfo
- Publication number
- FI961339A FI961339A FI961339A FI961339A FI961339A FI 961339 A FI961339 A FI 961339A FI 961339 A FI961339 A FI 961339A FI 961339 A FI961339 A FI 961339A FI 961339 A FI961339 A FI 961339A
- Authority
- FI
- Finland
- Prior art keywords
- therapy
- derivatives
- agents
- triarylethylene
- triarylethylene derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12661493A | 1993-09-24 | 1993-09-24 | |
| US08/259,797 US5525633A (en) | 1993-09-24 | 1994-06-15 | Triaryl-ethylene derivatives |
| PCT/US1994/009314 WO1995008528A1 (en) | 1993-09-24 | 1994-08-19 | Triaryl-ethylene derivatives for use in therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI961339A0 FI961339A0 (sv) | 1996-03-22 |
| FI961339A true FI961339A (sv) | 1996-03-22 |
Family
ID=26824862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI961339A FI961339A (sv) | 1993-09-24 | 1996-03-22 | Triaryletenderivat för användning i terapi |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5684004A (sv) |
| EP (1) | EP0720597B1 (sv) |
| JP (1) | JPH09503761A (sv) |
| CN (1) | CN1131415A (sv) |
| AT (1) | ATE165594T1 (sv) |
| AU (1) | AU678535B2 (sv) |
| CA (1) | CA2171728C (sv) |
| DE (1) | DE69409961T2 (sv) |
| DK (1) | DK0720597T3 (sv) |
| ES (1) | ES2115975T3 (sv) |
| FI (1) | FI961339A (sv) |
| HU (1) | HUT75933A (sv) |
| IL (1) | IL111018A0 (sv) |
| NO (1) | NO306292B1 (sv) |
| NZ (1) | NZ273433A (sv) |
| PL (1) | PL177833B1 (sv) |
| WO (1) | WO1995008528A1 (sv) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| EP2392258B1 (en) | 2005-04-28 | 2014-10-08 | Proteus Digital Health, Inc. | Pharma-informatics system |
| US8795627B2 (en) | 2007-03-21 | 2014-08-05 | Raptor Pharmaceuticals Inc. | Treatment of liver disorders by administration of RAP conjugates |
| AU2010216512B2 (en) | 2009-02-20 | 2016-06-30 | 2-Bbb Medicines B.V. | Glutathione-based drug delivery system |
| WO2010129819A2 (en) | 2009-05-06 | 2010-11-11 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1099093A (en) * | 1965-09-03 | 1968-01-17 | Ici Ltd | Alkene derivatives |
| DE2860900D1 (en) * | 1977-08-22 | 1981-11-05 | Ici Plc | Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
-
1994
- 1994-08-19 AU AU76707/94A patent/AU678535B2/en not_active Ceased
- 1994-08-19 EP EP94927182A patent/EP0720597B1/en not_active Expired - Lifetime
- 1994-08-19 CA CA002171728A patent/CA2171728C/en not_active Expired - Fee Related
- 1994-08-19 WO PCT/US1994/009314 patent/WO1995008528A1/en active IP Right Grant
- 1994-08-19 PL PL94313594A patent/PL177833B1/pl unknown
- 1994-08-19 ES ES94927182T patent/ES2115975T3/es not_active Expired - Lifetime
- 1994-08-19 DE DE69409961T patent/DE69409961T2/de not_active Expired - Fee Related
- 1994-08-19 DK DK94927182T patent/DK0720597T3/da active
- 1994-08-19 AT AT94927182T patent/ATE165594T1/de not_active IP Right Cessation
- 1994-08-19 HU HU9600727A patent/HUT75933A/hu unknown
- 1994-08-19 JP JP7509757A patent/JPH09503761A/ja not_active Ceased
- 1994-08-19 CN CN94193479A patent/CN1131415A/zh active Pending
- 1994-08-19 NZ NZ273433A patent/NZ273433A/en unknown
- 1994-09-21 IL IL11101894A patent/IL111018A0/xx unknown
-
1995
- 1995-06-05 US US08/463,792 patent/US5684004A/en not_active Expired - Fee Related
-
1996
- 1996-03-22 FI FI961339A patent/FI961339A/sv not_active IP Right Cessation
- 1996-03-25 NO NO961204A patent/NO306292B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL313594A1 (en) | 1996-07-08 |
| HUT75933A (en) | 1997-05-28 |
| ES2115975T3 (es) | 1998-07-01 |
| ATE165594T1 (de) | 1998-05-15 |
| WO1995008528A1 (en) | 1995-03-30 |
| FI961339A0 (sv) | 1996-03-22 |
| IL111018A0 (en) | 1994-11-28 |
| HU9600727D0 (en) | 1996-05-28 |
| NZ273433A (en) | 1997-11-24 |
| DE69409961T2 (de) | 1998-09-10 |
| AU678535B2 (en) | 1997-05-29 |
| NO961204L (no) | 1996-03-25 |
| PL177833B1 (pl) | 2000-01-31 |
| DK0720597T3 (da) | 1998-10-07 |
| NO961204D0 (no) | 1996-03-25 |
| NO306292B1 (no) | 1999-10-18 |
| EP0720597B1 (en) | 1998-04-29 |
| CN1131415A (zh) | 1996-09-18 |
| JPH09503761A (ja) | 1997-04-15 |
| EP0720597A1 (en) | 1996-07-10 |
| DE69409961D1 (de) | 1998-06-04 |
| US5684004A (en) | 1997-11-04 |
| AU7670794A (en) | 1995-04-10 |
| CA2171728C (en) | 2001-11-13 |
| CA2171728A1 (en) | 1995-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| MY104685A (en) | Substituted thiazoles and their use as fungicides. | |
| DK1036058T3 (da) | Adamantanderivater | |
| DK1036059T3 (da) | Adamantanderivater | |
| ID23374A (id) | Halogenopirimidin | |
| DE69106714D1 (en) | Hypoglykämische hydroxyharnstoffderivate. | |
| NO990405L (no) | Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler | |
| ATE233561T1 (de) | Imidazolverbindungen | |
| DK0711140T3 (da) | Antimykotisk opløsning til negle | |
| BR9711586A (pt) | Compostos e uso dos mesmo | |
| MX9201681A (es) | 4,5-dihidro-1h-pirazol-1-carboxiamidas 3,4,n-sustituidas y su uso como inseticidas. | |
| ATE167670T1 (de) | N-alkylthiopolyaminderivate als radioprotektive mittel | |
| ATE203519T1 (de) | Chinolinderivate als antimalariamittel | |
| PH30665A (en) | Aminosulfonyl urea acat inhibitors | |
| FI961339A0 (sv) | Triaryletenderivat för användning i terapi | |
| ES2152315T3 (es) | Xamoneline tartrato. | |
| NZ504614A (en) | Echinocandin derivatives and application as anti-fungal agents | |
| BR9611904A (pt) | Dioxidos de ditiazol | |
| ATE271878T1 (de) | Verwendung von protein h als zytostattischer wirkstoff | |
| ES1024223Y (es) | Unidad hermetica de uso personal. | |
| UA16247A1 (uk) | N-(3-ХЛОРО-1,4-HАФТОХІHОHІЛ-2)-2-Д, alРha-АСПАРАГІHОВУ КИСЛОТА, ЩО ПРОЯВЛЯЄ КАРДІОСТИМУЛЮЮЧІ ВЛАСТИВОСТІ | |
| ITFI930213A0 (it) | Pirrolidin-2-oni,loro preparazione,composizioni farmaceutiche che li contengono e loro uso in terapia. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired |